# US 2026/0008809 A1 · Protein purification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0008809 A1
- Document ID: US20260008809A1
- Status: Published application
- Kind: A1
- Application number: 18/881,807
- Filed: 2023-07-14
- Published: 2026-01-08
- Earliest claimed: 2022-07-14
- Assignees: Nuclera Ltd
- Applicants: Nuclera Ltd
- Inventors: Michael Chun Hao Chen
- Web page: https://patentgrep.com/patent/US20260008809A1

## CPC

- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- C07K 1/13: Labelling of peptides
- C07K 1/24: by electrochemical means
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- G01N 33/6839: {involving dyes, e.g. Coomassie blue, bromcresol green}
- C07K 2319/20: containing a tag with affinity for a non-protein ligand
- C07K 2319/21: containing a His-tag
- C07K 2319/22: containing a Strep-tag
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- G01N 33/6845: {Methods of identifying protein-protein interactions in protein mixtures}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention provided herein relates to methods for protein synthesis, purification and characterisation.

## Claims

### Claim 1

A method for protein synthesis comprising expressing a protein in a cell-free system wherein the expressed protein contains a sub-component of a fluorescent protein, the method comprising measuring the yield of expressed protein using a fluorescence measurement, purifying the protein by affinity purification, releasing the purified protein into solution and measuring the amount of expressed target protein and the total amount of protein in the solution.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the purified yield of protein is determined by fluorescence complementation.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the expressed protein contains a tag being a component of a fluorescent protein.

### Claim 4 (depends on 2)

The method according to claim 2, wherein the expressed protein contains ccGFP11.

### Claim 5 (depends on 1, 2, 3, 4)

The method according to any one of claims 1 to 4, wherein the affinity purification uses beads.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the affinity purification uses magnetic or paramagnetic beads.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method according to any one of claims 1 to 6, wherein the expression is performed using cell-free lysates.

### Claim 8 (depends on 7)

The method of claim 7, wherein the expression is performed using assembled components for transcription and translation in a system of purified recombinant elements (PURE).

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method according to any one of claims 1 to 8, wherein the affinity purification uses binding tags selected from:
Alfa-tag
(SRLEEELRRRLTE)
Avi-tag
(GLNDIFEAQKIEWHE)
C-tag
(EPEA)
Calmodulin-tag
(KRRWKKNFIAVSAANRFKKISSSGAL)
Dogtag
(DIPATYEFTDGKHYITNEPIPPK)
E-tag
(GAPVPYPDPLEPR)
FLAG
(DYKDDDDK)
G4T
(EELLSKNYHLENEVARLKK)
HA
(YPYDVPDYA)
His
(HHHHHH)
Isopeptag
(TDKDMTITFTNKKDAE)
lanthanide binding tag (LBT)
(FIDTNNDGWIEGDELLLEEG)
Myc
(EQKLISEEDL)
NE-Tag
(TKENPRSNQEESYDDNES)
Poly Glutamate-tag
(EEEEEEE)
Poly Arginine-tag
(RRRRRRR)
Rho1D4-tag
(TETSQVAPA)
SBP-tag
(MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREP)
Sdytag
(DPIVMIDNDKPIT)
SH3
(STVPVAPPRRRRG)
Snooptag
(KLGDIEFIKVNK)
Softag 1
(SLAELLNAGLGGS)
Softag 3
(TQDPSRVG)
Spot-tag
(PDRVRAVSHWSS)
Spytag
(AHIVMVDAYKPTK)
S-tag
(KETAAAKFERQHMDS)
Strep-tag
(AWAHPQPGG) (AWRHPQFGG)
Strep-tag II
(WSHPQFEK)
T7tag
(MASMTGGQQMG)
TC-tag
(EVHTNQDPLD)
Ty-tag
(CCPGCC)
VSV-tag
(YTDIEMNRLGK)
Xpress-tag
(DLYDDDDK)

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method according to any one of claims 1 to 9, wherein the immobilised protein are washed to further purify.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method according to any one of claims 1 to 10, wherein the assay to determine the total protein content uses Coomassie, Bicinchoninic acid or NanoOrange®.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method according to any one of claims 1 to 11, wherein the method is performed on a digital microfluidic device.

### Claim 13 (depends on 12)

The method according to claim 12 wherein the digital microfluidic device comprises an oil-filled or humidified gaseous environment, wherein the humidified gaseous environment is achieved by enclosing or sealing the digital microfluidic device and providing on-board reagent reservoirs.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method according to any one of claims 1 to 13 wherein a screening step identifies the optimal conditions for expression of the desired protein.

### Claim 15 (depends on 1)

The method according to claim 1 comprising
a. using a variety of different conditions to synthesise a protein of interest having a tag, thereby identifying the optimal conditions for the expression of soluble protein having the tag;
b. capturing the proteins via affinity to magnetic beads, thereby immobilising the proteins;
C. washing the beads;
d. eluting the protein from the beads; and
e. determining both the level of the correctly expressed tagged protein and the total amount of eluted protein.

### Claim 16 (depends on 1)

The method according to claim 1 comprising
a. using a variety of different conditions to synthesise and purify a protein of interest having a tag, thereby identifying the optimal conditions for the expression and purification of soluble protein having the tag by measuring the total concentration of purified protein and the yield of expressed protein to determine the expressed protein yield and purity of the synthesised protein.

### Claim 17

A protein having both a sequence which contains a sub-component of a fluorescent protein and a sequence for affinity purification.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method according to any one of claims 1 to 16 or a protein according to claim 17 wherein the protein contains a ccGFP11 peptide amino sequence tag selected from:
KRDHMVLLEFVTAAGITGT
KRDHMVLHEFVTAAGITGT
KRDHMVLHESVNAAGIT
RDHMVLHEYVNAAGIT
GDAVQIQEHAVAKYFTV
GDTVQLQEHAVAKYFTV
GETIQLQEHAVAKYFTE
or a truncated version thereof, and a binding tag selected from
Alfa-tag
(SRLEEELRRRLTE)
Avi-tag
(GLNDIFEAQKIEWHE)
C-tag
(EPEA)
Calmodulin-tag
(KRRWKKNFIAVSAANRFKKISSSGAL)
Dogtag
(DIPATYEFTDGKHYITNEPIPPK)
E-tag
(GAPVPYPDPLEPR)
FLAG
(DYKDDDDK)
G4T
(EELLSKNYHLENEVARLKK)
HA
(YPYDVPDYA)
His
(HHHHHH)
Isopeptag
(TDKDMTITFTNKKDAE)
lanthanide binding tag (LBT)
(FIDTNNDGWIEGDELLLEEG)
Myc
(EQKLISEEDL)
NE-Tag
(TKENPRSNQEESYDDNES)
Poly Glutamate-tag
(EEEEEEE)
Poly Arginine-tag
(RRRRRRR)
Rho1D4-tag
(TETSQVAPA)
SBP-tag
(MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREP)
Sdytag
(DPIVMIDNDKPIT)
SH3
(STVPVAPPRRRRG)
Snooptag
(KLGDIEFIKVNK)
Softag 1
(SLAELLNAGLGGS)
Softag 3
(TQDPSRVG)
Spot-tag
(PDRVRAVSHWSS)
Spytag
(AHIVMVDAYKPTK)
S-tag
(KETAAAKFERQHMDS)
Strep-tag
(AWAHPQPGG) (AWRHPQFGG)
Strep-tag II
(WSHPQFEK)
T7tag
(MASMTGGQQMG)
TC-tag
(EVHTNQDPLD)
Ty-tag
(CCPGCC)
VSV-tag
(YTDIEMNRLGK)
Xpress-tag
(DLYDDDDK)

### Claim 19 (depends on 18)

The protein according to claim 18 having a ccGFP11 region and a His, strep-tag or strep-II tag.

### Claim 20 (depends on 18, 19)

The protein according to claim 18 or claim 19 further having a region for solubility enhancement.

### Claim 21 (depends on 20)

The protein according to claim 20 wherein the solubility region is selected from maltose binding protein (MBP), Small Ubiquitin-like Modifier (SUMO), Glutathione S-transferase (GST), thioredoxin (TRX), T7 phage tail (P17), metal-binding protein (CUSF), 53-amino-acid-long N-terminal extension sequence (NEXT), Fasciola hepatica 8 kDa antigen (FH8), Solubility Enhancing Ubiquitous Tag (SNUT) or IgG repeat domain ZZ of Protein A (ZZ).

### Claim 22

A kit comprising reagents for cell-free protein synthesis, beads for purification of expressed proteins and reagents for measuring the total purified protein comprising Coomassie, Bicinchoninic acid or NanoOrange®.
